NCT05835804: Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers
- State
- Not started
- Phase
- Phase 2
- People
- 39 planned
- Started
- Nov 2025
- Primary completion
- Apr 2026
- Arms
- Intratumoral chemotherapy
- Results
- None posted
- 28 Apr 2023: Trial registered